Search Results - Judith Cave
- Showing 1 - 8 results of 8
-
1
-
2
The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis by Salma Naheed, Chloe Holden, Lulu Tanno, Eleanor Jaynes, Judith Cave, Christian H Ottensmeier, Giuseppe Pelosi
Published in BMJ Open (2019-08-01)Get full text
Article -
3
Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis by Salma Naheed, Chloe Holden, Lulu Tanno, Eleanor Jaynes, Judith Cave, Giuseppe Pelosi, Neil W Pearce, Bryan Green, Linda Pattini, Christian H. Ottensmeier
Published in BMJ Open (2022-03-01)Get full text
Article -
4
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phas... by Liz Darlison, Sean Ewings, Paul Taylor, Judith Cave, Gareth Griffiths, Zina Eminton, Dean Fennell, Charlotte Stuart, Daniel Griffiths, Abigail Morgan-Fox, Kayleigh Hill, Lucy Johnson, Kim Mallard, Mavis Nye, Sean Dulloo, Jin-Li Luo, Jake Spicer, Charlotte Poile, Aleksandra Bzura
Published in BMJ Open (2023-11-01)Get full text
Article -
5
Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis by Shobana Anpalakhan, Prerana Huddar, Roya Behrouzi, Alessio Signori, Judith Cave, Charles Comins, Alessio Cortellini, Alessio Cortellini, Alfredo Addeo, Carles Escriu, Hayley McKenzie, Gloria Barone, Lisa Murray, David J. Pinato, David J. Pinato, Christian Ottensmeier, Sara Campos, Sethupathi Muthuramalingam, Samuel Chan, Fabio Gomes, Giuseppe L. Banna
Published in Frontiers in Oncology (2023-05-01)Get full text
Article -
6
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer by Gary Middleton, Helen L. Robbins, Peter Fletcher, Joshua Savage, Manita Mehmi, Yvonne Summers, Alastair Greystoke, Nicola Steele, Sanjay Popat, Pooja Jain, James Spicer, Judith Cave, Paul Shaw, David Gilligan, Danielle Power, Dean Fennell, Maya Bajracharya, David J. McBride, Uma Maheswari, Alexander M. Frankell, Charles Swanton, Andrew D. Beggs, Lucinda Billingham
Published in npj Precision Oncology (2025-03-01)Get full text
Article -
7
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroen... by Mairéad G. McNamara, Jayne Swain, Zoe Craig, Rohini Sharma, Olusola Faluyi, Jonathan Wadsley, Carys Morgan, Lucy R. Wall, Ian Chau, Nick Reed, Debashis Sarker, Jane Margetts, Daniel Krell, Judith Cave, Sharmila Sothi, Alan Anthoney, Christopher Bell, Alkesh Patel, Jamie B. Oughton, David A. Cairns, Wasat Mansoor, Angela Lamarca, Richard A. Hubner, Juan W. Valle
Published in EClinicalMedicine (2023-06-01)Get full text
Article -
8
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations by James Artingstall, Alex Friedlaender, Alfredo Addeo, Judith Cave, Massimo Di Maio, Samuel Chan, Alessio Cortellini, Marcello Tiseo, Biagio Ricciuti, Francesco Facchinetti, Benjamin Besse, Joao V Alessi, Mark M Awad, David J Pinato, Giuseppe L Banna, Giuseppe Lamberti, Margarita Majem, Frank Aboubakar Nana, Charles Comins, Thomas Newsom-Davis, Victor R Vaz, Laura Mezquita, Davide Soldato, Filippo G Dall’Olio, Sethupathi Muthuramalingam, Aida Piedra, Elisa Andrini, Teresa Gorría, Delphine Hoton, Lacroix Valerie, Andrea Caglio, Hayley McKenzie, Joanne S Evans, Antonio D'Alessio, Claudia A M Fulgenzi
Published in Journal for ImmunoTherapy of Cancer (2022-02-01)Get full text
Article